Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).
|08/13/12||10-Q||Quarterly report pursuant to sections 13 or 15(d)||29|
|07/30/12||8-K||Current report filing||34|
|07/13/12||8-K||Current report filing||15|
|07/10/12||8-K||Current report filing
|07/09/12||8-K||Current report filing||33|
|06/19/12||8-K||Current report filing||27|
|06/12/12||8-K||Current report filing||23|
|06/07/12||424B3||Prospectus filed pursuant to Rule 424(b)(3)||115|
|06/06/12||EFFECT||Notice of Effectiveness||1|
|06/04/12||S-1/A||General form of registration statement for all companies including face-amount certificate companies